Literature DB >> 7852558

Epidemiologic investigation by macrorestriction analysis and by using monoclonal antibodies of nosocomial pneumonia caused by Legionella pneumophila serogroup 10.

P C Lück1, J H Helbig, U Günter, M Assmann, R Blau, H Koch, M Klepp.   

Abstract

A 67-year-old woman was hospitalized with an acute pneumonia of the left lower lobe. Legionella pneumophila serogroup 10 was cultured from two sputum specimens taken on days 18 and 20 and was also detected by direct immunofluorescence assay by using a commercially available species-specific monoclonal antibody as well as serogroup 10-specific monoclonal antibodies. Antigenuria was detected in enzyme-linked immunosorbent assays by using serogroup 10-specific polyclonal and monoclonal antibodies. In the indirect immunofluorescence test rising antibody titers against serogroups 1, 4, 5, 8, 9, 10, 14, and 15 were found in serum, with the highest titers found against serogroups 8, 9, and 10. L. pneumophila serogroups 10 and 6 and a strain that reacted with serogroup 4 and 14 antisera were cultured from both central and peripheral hot water systems of the hospital. Macrorestriction analyses of the genomic DNAs by pulsed-field gel electrophoresis showed that the isolate from the patient was identical to the serogroup 10 strains from the hospital hot water system. In contrast, the genomic DNAs of 16 unrelated L. pneumophila serogroup 10 strains showed 12 different restriction patterns. Monoclonal antibody subtyping revealed only minor differences in L. pneumophila serogroup 10 strains isolated from different sources. In conclusion, macrorestriction analysis is a valuable tool for studying the molecular epidemiology of L. pneumophila serogroup 10.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7852558      PMCID: PMC264144          DOI: 10.1128/jcm.32.11.2692-2697.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Common epitope on urinary antigen derived from different Legionella pneumophila serogroup 1 strains recognized by a monoclonal antibody.

Authors:  J H Helbig; P C Lück; C Pilz; W Witzleb
Journal:  Zentralbl Bakteriol       Date:  1990-09

Review 2.  Mode of transmission of Legionella pneumophila. A critical review.

Authors:  R R Muder; V L Yu; A H Woo
Journal:  Arch Intern Med       Date:  1986-08

3.  Genetic structure of populations of Legionella pneumophila.

Authors:  R K Selander; R M McKinney; T S Whittam; W F Bibb; D J Brenner; F S Nolte; P E Pattison
Journal:  J Bacteriol       Date:  1985-09       Impact factor: 3.490

4.  Isolation of Legionella pneumophila serogroup 3 from pericardial fluid in a case of pericarditis.

Authors:  P C Lück; J H Helbig; E Wunderlich; H Foelske; M Selbitschka; D Wenzel; L Pätzold; W Witzleb
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

5.  Legionella pneumophila serogroup Lansing 3 isolated from a patient with fatal pneumonia, and descriptions of L. pneumophila subsp. pneumophila subsp. nov., L. pneumophila subsp. fraseri subsp. nov., and L. pneumophila subsp. pascullei subsp. nov.

Authors:  D J Brenner; A G Steigerwalt; P Epple; W F Bibb; R M McKinney; R W Starnes; J M Colville; R K Selander; P H Edelstein; C W Moss
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies.

Authors:  J R Joly; R M McKinney; J O Tobin; W F Bibb; I D Watkins; D Ramsay
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

7.  Prevalence of Legionella species, serogroups, and monoclonal subgroups in hot water systems in south-eastern Germany.

Authors:  P C Lück; I Leupold; M Hlawitschka; J H Helbig; I Carmienke; L Jatzwauk; T Guderitz
Journal:  Zentralbl Hyg Umweltmed       Date:  1993-02

8.  Nosocomial legionellosis, Paris, France. Evidence for transmission by potable water.

Authors:  M A Neill; G W Gorman; C Gibert; A Roussel; A W Hightower; R M McKinney; C V Broome
Journal:  Am J Med       Date:  1985-04       Impact factor: 4.965

9.  Cross-reactive urinary antigens among patients infected with Legionella pneumophila serogroups 1 and 4 and the Leiden 1 strain.

Authors:  R B Kohler; L J Wheat; M L French; P L Meenhorst; W C Winn; P H Edelstein
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

10.  Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10.

Authors:  P L Meenhorst; A L Reingold; D G Groothuis; G W Gorman; H W Wilkinson; R M McKinney; J C Feeley; D J Brenner; R van Furth
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

View more
  14 in total

1.  Clinical and environmental isolates of Legionella pneumophila serogroup 1 cannot be distinguished by sequence analysis of two surface protein genes and three housekeeping genes.

Authors:  Helena Aurell; Pierre Farge; Hélène Meugnier; Manolo Gouy; Françoise Forey; Gérard Lina; François Vandenesch; Jerome Etienne; Sophie Jarraud
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

2.  A large Legionnaires' disease outbreak in Pamplona, Spain: early detection, rapid control and no case fatality.

Authors:  J Castilla; A Barricarte; J Aldaz; M García Cenoz; T Ferrer; C Pelaz; S Pineda; B Baladrón; I Martín; B Goñi; P Aratajo; J Chamorro; F Lameiro; L Torroba; I Dorronsoro; V Martínez-Artola; M J Esparza; M A Gastaminza; P Fraile; P Aldaz
Journal:  Epidemiol Infect       Date:  2007-07-30       Impact factor: 2.451

3.  A community outbreak of Legionnaires' disease associated with a cooling tower in Vic and Gurb, Catalonia (Spain) in 2005.

Authors:  M R Sala Ferré; C Arias; J M Oliva; A Pedrol; M García; T Pellicer; P Roura; A Domínguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-28       Impact factor: 3.267

4.  Comparison of Legionella pneumophila isolates by arbitrarily primed PCR and pulsed-field gel electrophoresis: analysis from seven epidemic investigations.

Authors:  J M Pruckler; L A Mermel; R F Benson; C Giorgio; P K Cassiday; R F Breiman; C G Whitney; B S Fields
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

5.  Field inversion gel electrophoretic analysis of Legionella pneumophila strains associated with nosocomial legionellosis in children.

Authors:  M Green; E R Wald; B Dashefsky; K Barbadora; R M Wadowsky
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Single clonal origin of a high proportion of Legionella pneumophila serogroup 1 isolates from patients and the environment in the area of Paris, France, over a 10-year period.

Authors:  C Lawrence; M Reyrolle; S Dubrou; F Forey; B Decludt; C Goulvestre; P Matsiota-Bernard; J Etienne; C Nauciel
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Nosocomial pneumonia caused by three genetically different strains of Legionella pneumophila and detection of these strains in the hospital water supply.

Authors:  P C Lück; H M Wenchel; J H Helbig
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  DNA polymorphisms in strains of Legionella pneumophila serogroups 3 and 4 detected by macrorestriction analysis and their use for epidemiological investigation of nosocomial legionellosis.

Authors:  P C Lück; J Köhler; M Maiwald; J H Helbig
Journal:  Appl Environ Microbiol       Date:  1995-05       Impact factor: 4.792

9.  Legionella pneumophila serogroup 1 strain Paris: endemic distribution throughout France.

Authors:  Helena Aurell; Jerome Etienne; Françoise Forey; Monique Reyrolle; Pascale Girardo; Pierre Farge; Bénédicte Decludt; Christine Campese; François Vandenesch; Sophie Jarraud
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  DNA fingerprinting by pulsed-field gel electrophoresis to investigate a nosocomial pneumonia caused by Legionella bozemanii serogroup 1.

Authors:  P C Lück; J H Helbig; H J Hagedorn; W Ehret
Journal:  Appl Environ Microbiol       Date:  1995-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.